CERO
CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. (CERO)
$01
About CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. (CERO)
CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. The company was founded on June 8, 2021 and is headquartered in South San Francisco, CA.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$5.66
52 Week Low
$0.01
Market cap
730,600
Dividend yield
-
Volume
--
Avg. volume
707,890
P/E ratio
.00
CERO TERAPEUTICS HLDG INC by CERo Therapeutics Holdings, Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$5.66
52 Week Low
$0.01
Market cap
730,600
Dividend yield
-
Volume
--
Avg. volume
707,890
P/E ratio
.00